INTRODUCTION: In the face of unchanging high rates of stunting among 12-23 months old Filipino babies, sustaining exclusive breastfeeding up to 6 months old remains a challenge. This study determined the effect of a breastfeeding reminder system on breastfeeding. METHODS: This is a quasi-experimental study. Mothers were regularly given breastfeeding reminders by SMS and phone call. The weight, body length, episodes of upper respiratory tract infection and diarrhea were compared between the babies who were given exclusive breastfeeding and those whose exclusive breastfeeding was not sustained. Pearson Chi – square test and t-test at p=0.05 determined significance of differences of variables. RESULTS: From March- October 2020, there were 450 babies included in the study. Of these babies, 44.8% were given exclusive breastfeeding up to 6 months. Timely initiation of breastfeeding was practiced by 91.95% of the mothers in the study. Babies who did not receive exclusive breastfeeding were shorter than those who received exclusive breastfeeding at 1 year old (70.11cm +2.78 vs.75.47cm +1.41, p<0.001) and at 2 years old (80.89 cm +2.30 vs. 87.29cm +1.47, p<0.001). At 2 years old, babies who received exclusive breastfeeding had no episodes of diarrhea and minimal (2%, p<0.001) episodes of acute respiratory infections. CONCLUSION Due to the implementation of the reminder system, the percentage of babies exclusively breastfed up to 6 months of age increased to 44%. This is a significant improvement compared to a previous study where only 29% of the babies were exclusively breastfed.At one and two years old, babies who were not exclusively breastfed had stunting, weighed less and had more infections (diarrhea and URTI).
exclusive breastfeeding ; infants ; stunting

Vitamin B12 deficiency in exclusively breastfed infants is an important problem in developing countries. Vitamin B12 deficiency is associated with a wide spectrum of clinical manifestations. Few cases of vitamin B12 deficiency have been reported as the cause of infantile spasms. We report the case of a 6-month-old boy diagnosed with infantile spasms associated with vitamin B12 deficiency caused by nutritional inadequacy in the mother. He was observed to have head nods and flexor limbs spasms which appeared in clusters. Psychomotor development was normal. The serum vitamin B12 level was low and results of electroencephalography (EEG) indicated modified hypsarrhythmia. His symptoms resolved after synthetic adrenocorticotropic hormone (ACTH) and vitamin B12 treatment. The EEG was completely normal after the first month and sixth month of treatment. In addition to ACTH and vitamin B12 treatment, following antiepileptic drug treatment was not initiated. During 21 months’ follow up he is seizure-free and his neurological development is age-appropriate. This case of a 6 month-old infant with infantile spasms due to vitamin B12 deficiency seems to be a striking because of only with vitamin B12 and ACTH treatment the patient became seizure-free. Vitamin B12 deficiency may be a treatable cause of infantile spasms and should be considered in the associated cause of infantile spasms especially if nutritional inadequacy in the mother.
Vitamin B 12 Deficiency ; Infants

This patient was born at 25th week of gestation with extremely low birth weight (700 grams) and hyaline membrane disease. On his 9th day as neonate, he was diagnosed to have a patent ductus arteriosus (PDA). Due to pulmonary congestion/ hypertension on top of failure of the said PDA to close after a regimen of ibuprofen and subsequently indomethacin, surgical intervention was contemplated which however was delayed because of the onset of pneumonia and bronchopulmonary dysplasia. On the 59th day of life, PDA ligation was done at the Nursery ICU. The patent weighted 800 grams at his supposed to be 33- 34 weeks age of gestation making him the smallest infant to be reported who have underwent PDA ligation in the Philippines.
Human ; DUCTUS ARTERIOSUS, PATENT ; INFANT, LOW BIRTH WEIGHT ; PREMATURE BIRTH ; INFANTS ; NEUROMUSCULAR BLOCKING AGENTS ; HYALINE MEMBRANE DISEASE ; LIGATION